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Iron is an essential nutrient for bacterial growth. Therefore, bacteria have evolved
chelation mechanisms to acquire iron for their survival. Enterobactin, a chelator with
high affinity for ferric iron, is secreted by Escherichia coli and contributes to its
improved bacterial fitness. In this preliminary study, we evaluated enterobactin deficiency
both in vitro and in vivo in the context of E. coli mastitis. Firstly, we showed that
expression of lipocalin 2, a protein produced by the host that is able to both bind
and deplete enterobactin, is increased upon E. coli infection in the cow’s mastitic
mammary gland. Secondly, we demonstrated in vitro that enterobactin deficiency
does not alter interleukin (IL)-8 expression in bovine mammary epithelial cells and its
associated neutrophil recruitment. However, a significantly increased reactive oxygen
species production of these neutrophils was observed. Thirdly, we showed there was
no significant difference in bacterial in vitro growth between the enterobactin-deficient
mutant and its wild-type counterpart. However, when further explored in a murine
model for bovine mastitis, the enterobactin-deficient mutant vs. the wild-type strain
revealed a significant reduction of the bacterial load and, consequently, a decrease in
pro-inflammatory cytokines (IL-1α,−1β,−4,−6, and−8). A reduced neutrophilic influx
was also observed immunohistochemically. These findings therefore identify interference
of the enterobactin iron-scavenging mechanism as a potential measure to decrease the
fitness of E. coli in the mastitic mammary gland.
Keywords: E. coli mastitis, enterobactin, iron scavenging, siderophores, lipocalin 2 (also known as NGAL)
INTRODUCTION
Iron (Fe) is an essential micronutrient and co-factor in several oxidation–reduction reactions
required for basic cell metabolism, e.g., DNA stability and cell cycle control (1, 2). In mammals,
iron availability is tightly regulated by host iron-binding proteins such as transferrin, ferritin,
and lactoferrin. The latter is specifically secreted in milk in order to limit bacterial growth (3, 4).
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However, bacteria secrete high affinity iron-binding siderophores
to circumvent iron restriction by the host. Enterobactin (Ent) is
a prototypic siderophore that is highly conserved in Escherichia
coli, being optimally structured for binding ferric iron (5–
7). For its synthesis, Ent relies on the conversion of amino
acid precursors by the non-ribosomal peptide synthetase EntA
which catalyzes an early step in Ent biosynthesis (6, 8, 9). The
production of siderophores like Ent is particularly induced under
low iron level conditions, aiding bacteria in their competition
with the host for scarcely available iron (1, 10). The role of
Ent is especially well-studied in the inflamed gut in which iron-
bound Ent from intestinal E. coli clearly contributes to pathogen
growth and immune resistance during disease development (11–
13). Therefore, Ent and other siderophores have been identified
as potential preventive or therapeutic targets in general and
have shown some applicability, also to bovine mastitis pathogens
(14, 15). Bovine mastitis, an inflammation of the cow’s udder,
is currently the most prevalent production disease in the dairy
industry and is frequently caused by E. coli (16, 17). Escherichia
coli is an environmental pathogen that takes advantage of poor
hygiene conditions and is best controlled with appropriate
farm and animal management measures (18). However, full
eradication of E. coli mastitis even with these appropriate
measures implemented proves impossible (19).
Bacterial siderophores have been associated with lipocalin
2 (LCN2) released by host immune cells, primarily
polymorphonuclear neutrophilic granulocytes (PMN), as
part of their immune response against propagating pathogens
(11–13, 20). LCN2 is able to bind and deplete both iron-bound
and iron-lacking bacterial siderophores, thus further preventing
iron uptake by bacteria (12, 21, 22). These LCN2-producing
PMN are attracted to the infected mammary gland by the
chemotactic molecule interleukin (IL)-8 that is secreted by
the bovine mammary epithelium to enhance phagocytosis and
reactive oxygen species (ROS) production of PMN to clear the
infection present (23, 24).
However, the interplay between bacterial Ent and the host’s
immune system remains poorly studied in the context of E.
coli mastitis (25). For this purpose, limited in vitro and in
vivo studies were combined to preliminarily investigate the
involvement of iron availability, innate immunity, and a local
bacterial infection.
MATERIALS AND METHODS
Selection of E. coli Strains
Three E. coli strains were selected: P4, 1303, and MG1655. The
P4 strain consisted of a wild-type bovine mastitis isolate (P4)
as well as its genetically modified EntA-deficient counterpart
(P4 1entA) unable to produce enterobactin. To demonstrate
a strain-independent effect, E. coli strains 1303 and MG1665
were included additionally. Escherichia coli 1303 is bovine
mastitis-derived, and E. coli MG1655 is a non-pathogenic E.
coli K-12 derivative (26, 27). All E. coli strains were grown
in Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Thermo
Fisher Scientific) at 37◦C and 5% CO2.
Quantitative Polymerase Chain Reaction of
LCN2 mRNA in Udder Tissue of
Experimentally E. coli-Infected Dairy Cows
The experimental procedures on the cows were executed at
the Clinic for Ruminants in Munich under ethical approval
by the regional government ethics committee of upper Bavaria
(approval number 55.2-1-54-2531-108-05). Five mid-lactating
Holstein Friesian cows were experimentally infected in one
quarter with either 500 colony-forming units (CFU) of E. coli
mastitis isolate 1303 or were sham-inoculated (28). Prior to the
infection, milk samples of all udder quarters confirmed normal
somatic cell counts (50,000 somatic cells/ml) and the absence
of mastitis pathogens. Twelve hours post-infection (h.p.i.), all
inoculated animals displayed clinical mastitis in the affected
quarters. Animals were humanely euthanized 24 h.p.i. following
the recommended guidelines of the American Veterinary
Medical Association (“AMVA Guidelines for the Euthanasia of
Animals”), and ∼100mg of lobulo-alveolar udder tissue was
snap frozen in liquid nitrogen immediately after euthanasia.
RNA was extracted from the udder tissue of the E. coli-
infected cows using TRIzol (Invitrogen). Reverse transcription
of 100 ng total RNA into cDNA was performed using iScript
Reverse Transcription Supermix (Bio-Rad). Subsequently, iQ
SYBR Green Supermix (Bio-Rad) was used for quantitative
polymerase chain reaction (qPCR) with the primers described
in Supplementary Table 1. Expression of two reference genes
PPIA and 18S, according to MIQE guidelines, was used for
normalization, and Genex macro (Bio-Rad) then calculated the
final gene expression in infected vs. uninfected udder quarters
from the same cow (29).
IL-8 Expression of E. coli-Exposed Bovine
Mammary Epithelial Cells
Two bovine mammary epithelial cell lines (boMECs), MAC-
T and PS, were exposed to either E. coli P4, P4 1entA,
1303, or MG1665 as described (30). Briefly, boMECs were
seeded to flat microtiter plates to contain 105 cells/well in
assay medium DMEM/F12 (Thermo Fisher Scientific) and
grown to confluence at 37◦C and 5% CO2 for 72 h (31).
Prior to infection of boMECs, E. coli strains were inoculated
into DMEM/F12 and grown standing at 37◦C for 2–4 h to
reach OD600 = 0.4 before diluting to 10
6 CFU/ml. After co-
incubation of each E. coli with boMECs for 3 h, supernatants
were collected. Escherichia coli were removed by washing
with Hanks’ balanced salt solution (HBSS) (Gibco) and media
replenished supplemented with 50µg/ml gentamycin (Sigma) for
a further 21 h. Supernatants were additionally collected at 24 h.
Secreted IL-8 levels were then measured in the supernatant of
both exposed boMECs by enzyme-linked immunosorbent assay
(ELISA) as described (32).
Isolation and Migration of and Reactive
Oxygen Species Production by PMN After
Co-culture With E. coli-Exposed boMECs
Migration of PMNwas evaluated by a transwell assay. PMN were
isolated from peripheral bovine blood by density centrifugation
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and flash lysis as described (33). PMN purity was assessed by
microscopy after Diff-Quik (Reagena) staining. Isolations that
were at least 90% pure were subsequently used for migration
assays. The latter were performed using transwell inserts for 24-
well tissue culture plates containing a pore size of 2µm (Greiner).
BoMECs were introduced into 24-well plates at a concentration
of 105 cells/well and allowed to adhere overnight. Cells were
washed andmedia replaced with E. coli isolates at a multiplicity of
infection (MOI) of 105 CFU/well, arbitrarily set as 1 (MOI = 1).
Media alone and recombinant bovine IL-8 (Kingfisher Biotech) at
5µg/ml served as the negative and positive control, respectively.
PMN were immediately added to the inner transwell at 106
cells/well and subsequently incubated during 24 h. Migration was
assessed 3 and 24 h after E. coli exposure using modified counting
chambers (Immune Systems) as described (34). Reactive oxygen
species production of PMNwas investigated by culturing isolated
PMN in HBSS either in the presence of P4 or P4 1entA
heat-killed E. coli. Reactive oxygen species was measured as
described (35). Briefly, production of ROS by PMNwasmeasured
by oxidation of 2,7-dichlorofluorescein diacetate (DCFH-DA)
(Sigma) to fluorescent 2,7-dichlorofluorescein (DCFH) at 2 h
post-exposure in black microtiter plates. Zymosan-stimulated
and unstimulated PMN served as positive and negative control,
respectively. Relative fluorescence units were measured using
a spectrophotometer (Tecan M200) at 485 nm excitation and
530 nm emission wavelengths, while cells were incubated at 37◦C
and 5% CO2.
In vitro Growth Curves of E. coli P4 and E.
coli P4 1entA
An overnight bacterial culture was diluted 1:100 in DMEM/F12
(Thermo Fisher Scientific) and vortexed. Subsequently, 200 µl
thereof was added to wells in a 96-well plate. This 96-well plate
was thereafter incubated at 37◦C and the optical density was
measured at 600 nm (OD600) every hour during 8 h.
Mouse Model for Bovine E. coli Mastitis
and Processing of the Harvested E.
coli-Infected Mammary Glands
All experimental procedures on mice were executed at the
Faculty of Veterinary Medicine of Ghent University (Merelbeke,
Belgium) and with approval of the ethics committee (Approval
Number 2015/127). In brief, female C57BL/6 and CD-1 mice
(purchased from Envigo) were coupled with male mice. Ten days
post-partum, the lactating dams were intraductally inoculated
with a 32-gauge pediatric needle in the fourth abdominal
mammary gland pair after properly disinfecting the teat.
Intraductal inoculations were performed with an inoculum dose
of ∼250 CFU at 1 h post-weaning of either P4 or P4 1entA
in 100 µl phosphate buffered saline (PBS). This inoculation
was performed under general gas anesthesia, using a mixture
of oxygen and isoflurane at 2–3% for induction and 1–
1.5% for maintenance. The long-acting analgesic buprenorphine
(Vetergesic, Patheon UK Ltd., Swindon, UK) was administered
at 10 µg/kg intraperitoneally for post-surgical pain relief. At
24 h.p.i., the inoculated mice were sedated with a cocktail
FIGURE 1 | mRNA lipocalin 2 (LCN2) relative expression calculated by the
11Ct method taking as reference genes PPIA and 18S in udder quarters
24 h.p.i. with 500 colony-forming units (CFU) E. coli 1303 compared with
sham-inoculated udder quarters (nquarters = 5 per condition). Data are
presented as means ± standard error of the mean. **P < 0.01.
of 100 mg/kg ketamine (Ketamidor, Ecuphar nv/sa, Belgium)
and 10 mg/kg xylazine (Xylazini Hydrochloridum, Val d’Hony-
Verdifarm, Belgium) and subsequently euthanized by cervical
dislocation to harvest the mammary glands. In order to quantify
the bacterial loads (expressed as CFU), the isolated mammary
glands were homogenized using TissueRuptor (Qiagen) and
serially diluted in PBS, followed by plating on tryptic soy
agar (Oxoid). To compensate for the different volumes of the
harvested tissues, mammary glands were weighed and bacterial
load was expressed as CFU/g tissue.
The host response to the experimental mammary gland
infection was investigated by determining the levels of LCN2
and selected inflammatory cytokines in mammary gland
lysates obtained by mixing the homogenates with 300 µl lysis
buffer containing protease inhibitors. Quantification of LCN2
was performed by ELISA (Bio-Techne, Minneapolis, MN,
USA). Levels of the selected cytokines IL-1α,−1β,−4,−6,
and−8 were determined by multiplex assay (Luminex,
Thermo Fisher Scientific). Neutrophil influx was evaluated
by immunohistochemical staining for the neutrophil marker
Ly6G (anti-Ly6G-APC, clone 1A8, Miltenyi Biotec) on paraffin
sections of the infected mouse mammary glands at 24 h.p.i.
Deparaffinized and hydrated tissue slides were incubated
in citrated buffer at pH 6.0 (10mM tri-sodium citrate and
0.05% Tween-20) in a decloacking chamber under pressure at
95◦C for 30min. Following peroxidase blocking [3% H2O2 in
methanol for 10min at room temperature (RT)], sections were
incubated with primary rat anti-mouse Ly6G antibody for 1 h
at RT. Rat-on-mouse HRP-Polymer (Biocare Medical) served
as secondary antibody on the tissue sections for 30min at RT.
Detection of the staining was performed by applying a buffer
with 3,3′-diaminobenzidine on the tissue sections for 10min at
RT. For microscopic evaluation of this immunohistochemical
staining, the tissue sections were rehydrated and mounted with a
cover glass.
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FIGURE 2 | Secreted interleukin (IL)-8 concentrations by bovine mammary epithelial cell lines (boMECs) as measured in the supernatant of bovine MAC-T (A) and PS
(B) cells at both 3 and 24 h after co-incubation with E. coli P4 1entA vs. P4 and two additional E. coli strains, i.e., 1303 and MG1655. Each cell type and incubation
time had six replicates (n = 6). Data are presented as means ± standard error of the mean.
Statistical Analysis
Data were analyzed using GraphPad Prism (version 5.00.288)
to calculate P-values and determine statistically significant
differences (P < 0.05). D’Agostino-Pearson was used to check
for normally distributed data. If needed, data underwent a log10
transformation, leading to a normal distribution of the data. Two
groups were compared with unpaired t-tests, andmultiple groups
with analysis of the variance (ANOVA) and Tukey’s post hoc-test.
RESULTS
Expression of Host LCN2 Is Increased in
the E. coli-Infected Mammary Gland
To confirm that iron is sequestered in the cow’s mastitic
mammary gland by the host’s immune system, Holstein Friesian
cows were experimentally infected with E. coli 1303 and LCN2
expression was determined. qPCR analysis revealed that LCN2
expression in the E. coli-infected bovine mammary gland
tissue was indeed significantly increased compared with sham-
inoculated quarters (P < 0.01; Figure 1).
Since our group previously observed the Ent expression
system is commonly present in mastitis-causing E. coli (36) and
the role of LCN2 includes sequestration of bacterial Ent, this
observation in the target species raises a subsequent question:
How is the host’s immune response, i.e., chemokines produced
by boMECs, PMN migration, and activation, affected in the
presence and absence of bacteria producing Ent? Therefore,
a bovine mastitis-derived E. coli strain, i.e., P4, was made
deficient in the EntA gene, and Ent deficiency was preliminarily
determined in vitro on the previously mentioned cell types.
IL-8 Secretion Is Not Altered in BoMECs by
Bacterial Ent Depletion
IL-8 secretion, a key inflammatory marker of mastitis, was
determined as a first parameter in two boMEC lines [i.e., MAC-T
(Figure 2A) and PS (Figure 2B)] upon incubation with E. coli P4
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FIGURE 3 | (A,B) Transwell migration of bovine blood-derived polymorphonuclear neutrophilic granulocytes (PMN) to boMEC lines MAC-T and PS incubated either 3
or 24 h with E. coli P4 1entA vs. P4 and two additional E. coli strains: 1303 and MG1655. Recombinant IL-8 and the absence of bacteria were used as positive and
negative control, respectively. (C) Reactive oxygen species (ROS) production in relative fluorescence units (RFU) by bovine blood PMN measured at 485 nm excitation
and 530 nm emission wavelengths for 120min following incubation with E. coli P4 1entA vs. P4. Zymosan-stimulated PMN served as a positive control and were
compared with unstimulated PMN as a negative control. Each cell type and incubation time had at least three replicates (n ≥ 3). Data are presented as means ±
standard error of the mean. ***P < 0.001.
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FIGURE 4 | Growth curves of E. coli P4 and P4 1entA in DMEM/F12. Overnight bacterial cells were diluted 1:100 and 200 µl of the diluent was added to 12 (n = 12)
wells in a 96-well plate. Optical density was measured at 600 nm (OD600) every hour during 8 h while incubating the plate at 37
◦C. Data are presented as means ±
standard deviation. No significant statistical differences were observed (P > 0.05).
and its enterobactin-deficient counterpart: P4 1entA. BoMECs
were incubated either with or without bacteria for 3 or 24 h.
Untreated BoMECs showed very low levels of IL-8 secretion after
3 h and no increase in their IL-8 secretion over time at 24 h
(Figure 2). The IL-8 secretion of boMECs incubated with E. coli
P4 1entA vs. E. coli P4 did not differ significantly (P > 0.05;
Figure 2). To confirm that this single observation was P4 strain-
independent, boMECs were additionally incubated with two
other E. coli strains, i.e., the bovine mastitis-derived E. coli 1303
and the non-pathogenic, human-derived E. coli MG1655. Both
strains induced secretion of similar amounts of IL-8 compared
with P4 and P4 1entA (Figure 2). It was also observed that
increased incubation times from 3 to 24 h resulted in higher
concentrations of secreted IL-8 in both boMEC lines and with
all E. coli tested, but no differential secretion was observed upon
Ent depletion.
Bacterial Ent Depletion Does Not Alter
PMN Migration but Influences ROS
Production
Secondly, to investigate whether the unaltered IL-8 expression
levels did not affect PMN functionality, PMN migration and
ROS production of PMN were determined under the same
experimental conditions.
BoMECs were incubated either with or without the different
E. coli strains, and PMN migration was subsequently evaluated
using a transwell assay. Similarly as for IL-8 secretion, PMN
migration did not differ significantly between P4 1entA and P4
(P > 0.05; Figures 3A,B). Longer incubation times resulted in a
higher number of migrated PMN, but again no differential effect
of Ent depletionwas observed. The lack of differences was not due
to a functional impairment of PMN, as PMNmigrated strongly in
the presence of added bovine IL-8 (positive control). After 24 h,
this positive control had the highest number of migrated PMN.
Furthermore, all wells containing either treated boMEC or IL-
8 contained more migrated PMN compared with the negative
control (untreated boMEC), although no statistically significant
difference was observed either between the E. coli strains tested
and the controls on both boMEC cell lines and as a result of
increased incubation times (P > 0.05; Figures 3A,B). Finally,
PMN migrated in general less when the wells contained only the
bacterial isolates compared to incubation with E. coli-exposed
boMECs (data not shown).
In order to determine if Ent affected oxidative antimicrobial
responses of PMN, ROS production in response to P4 and
P4 1entA was measured. Interestingly, measuring fluorescence
intensity as marker for ROS production was significantly
increased in bovine PMN incubation with P4 1entA compared
with P4 (P < 0.001; Figure 3C). The level of ROS production
of PMN in response to P4 1entA was similar to the ROS
productionmeasured in zymosan-stimulated PMN, which served
as a positive control. Unstimulated and P4-stimulated PMN
produced similar amounts of ROS, indicating that wild-type P4
might interfere with ROS production (Figure 3C).
E. coli P4 and P4 1entA Show a Similar in
vitro Growth
Demonstrating that there is no negative impact of enterobactin
depletion on IL-8 expression, PMN migration, and activation
in an in vitro setting, it was subsequently investigated whether
the fitness of E. coli was hindered by Ent deficiency in vitro.
Escherichia coli P4 and P4 1entA were separately grown in
DMEM/F12 under the same experimental conditions, and the
OD600 was measured every hour during 8 h. Both bacteria
showed a similar growth curve and no significant differences
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FIGURE 5 | Bacterial load expressed as CFU/g mammary gland in C57BL/6
(A) (n ≥ 12) and CD-1 (B) (n = 4) mice at 24 h.p.i. with E. coli P4 1entA (dots)
vs. P4 (squares). Data are presented as single sample values. The bar
indicates the mean. ***P < 0.001.
were observed (Figure 4). This observation therefore indicates E.
coli P4 1entA has no reduced fitness relative to E. coli P4 under
the determined experimental conditions.
P4 1entA-Infected Murine Mammary
Glands Show Lower Bacterial Loads and a
Decreased Inflammatory Response
Compared With P4-Infected Glands
To investigate the influence of Ent depletion on E. coli
growth in vivo, a situation in which iron availability is more
tightly regulated, murine mammary glands were intraductally
inoculated with E. coli P4 and P4 1entA. Bacterial loads in P4
1entA-infected mammary glands were significantly decreased
compared with P4-infected glands at 24 h.p.i. (P < 0.001;
Figure 5). This observation was mouse strain-independent as
consistent observations were obtained in both C57BL/6 and CD-
1 mouse strains (Figure 5). Concomitant with the reduced IL-8
levels analyzed in mammary gland homogenates, Ly6G staining
of mammary gland tissue showed a significantly decreased influx
of PMN in the alveolar lumen upon mammary gland infection
with P41entA compared with that seen in P4-infectedmammary
glands (P < 0.001; Figure 6). Similar to the reduced levels of
IL-8, levels of pro-inflammatory cytokines IL-1α,−1β,−4, and−6
as well as LCN2 were also reduced upon P4 1entA infection in
mammary gland homogenates of both mouse strains compared
with their P4-infected counterparts (P ≤ 0.08; Figure 7).
DISCUSSION
Due to the high prevalence of bovine mastitis and the consecutive
overuse of antibiotics in the dairy industry, novel compounds
that target other determinants such as bacterial fitness factors
are desired (16, 35). Limiting iron uptake of E. coli, regarded an
essential bacterial growth factor, could offer such antimicrobial
potential (14, 37). In this preliminary host–pathogen interaction
study, we demonstrated the potential of decreasing the fitness
of E. coli in the murine mammary gland if E. coli is Ent
deficient. This decreased fitness was observed with significantly
reduced bacterial loads in murine mammary gland lysates
and, consequently, a decreased inflammatory response which
was characterized by diminished chemokine levels and less
infiltration of PMN.
Contradictory to our in vivo observations, we demonstrated
that bacterial Ent depletion did not impact on IL-8 secretion
by the bovine mammary epithelium and its associated PMN
migration in vitro. It must be noted that these experiments
were all performed in DMEM/F12, implying there was most
likely no significant difference in bacterial growth between E.
coli P4 1entA and its P4 wild-type counterpart, because both
bacteria showed similar growth patterns in this culture medium.
It is therefore highly likely that this similar in vitro bacterial
growth is responsible for the absence of differences observed in
our other in vitro assays. Performing these assays again under
iron-restricted conditions might reveal novel data that more
closely mimic the outcomes of our murine model, and as such,
this should be regarded a follow-up experiment. In fact, E. coli
features more mechanisms than just Ent to acquire iron, which
might have compensated for the Ent deficiency of E. coli P4
1entA when grown in high iron containing DMEM/F12 (1, 3, 4).
To proceed with our in vitro observations, it was also noticed
that PMN might have significantly improved phagocytosis and
enzymatic activity in their phagosomes if E. coli is Ent deficient,
although more research remains warranted to fully confirm this
statement. Nonetheless, a higher ROS production by PMN in the
E. coli P4 1entA-infected murine mammary glands is another
possible factor that might have contributed to the observed
differences between the E. coli P4 1entA vs. P4-infected mouse
mammary glands. Furthermore, it should also be noticed that our
in vitro research was limited to the interplay between boMECs
and PMN. Our goal in this preliminary study was to evaluate
the presence of Ent on the established biomarkers of mastitis,
primarily IL-8 produced by boMECs and its associated PMN
recruitment and activation (38). However, also other cell types
such as macrophages are known to play a crucial role in the
latter mentioned processes (38, 39). A previous study of our
group showed that macrophages are major secretors of LCN2
upon mammary gland infection (39). Including macrophages
to these in vitro assays, which can also be proposed as a
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FIGURE 6 | Concentration of the PMN chemoattractant IL-8 and immunohistochemical staining of PMN (Ly6G) in mammary glands of C57BL/6 (A) (n ≥ 12) and
CD-1 (B) (n = 4) mice at 24 h.p.i. with E. coli P4 1entA vs. P4. Scale bar = 50µm. Data are presented as means ± standard error of the mean. *P < 0.05;
**P < 0.01; ***P < 0.001.
follow-up experiment, could drastically change E. coli growth,
IL-8 levels, and concomitant PMN recruitment and activation.
Taken together, (1) the high iron availability in vitro, (2) a
higher ROS production by PMN in E. coli P4 1entA, and (3)
the presence of macrophages in the murine mammary gland
are factors that most likely contributed to the contradictory
observations between our in vitro and in vivo data.
In comparison, another study also reports the reduced
bacterial fitness of an E. coli P4 fec deletion mutant (E. coli
P4 1fec), which is an iron-acquiring mechanism to capture
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FIGURE 7 | Levels of pro-inflammatory cytokines IL-1α (A), IL-1β (B), IL-4 (C), and IL-6 (D) and of LCN2 (E) in mammary glands of C57BL/6 (n ≥ 12) and CD-1 (n =
4) mice at 24 h.p.i. with E. coli P4 1entA vs. P4. Data are presented as means ± standard error of the mean. *P < 0.05 and **P < 0.01.
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ferric citrate (10). This fec-lacking E. coli P4 mutant was not
capable anymore to induce mastitis in cows in comparison
with the E. coli P4 wild type (10). Our E. coli P4 1entA was
challenged at a similar CFU/ml in mice and was still able to
establish infection, but significantly lower bacterial loads were
observed. Our findings in mice are therefore in line with the
observationsmade in the bovine target species, although it should
be noticed that a direct comparison between these two E. coli
that are deficient in different iron acquisition mechanisms and
were evaluated in different species remains difficult. Therefore,
a follow-up study in which cows are challenged with E. coli P4
1entA urges to allow a correct comparison between E. coli P4
1entA and E. coli P4 1fec. Nonetheless, our preliminary results
in mice together with the observations made for E. coli P4 1fec
in dairy cattle pinpoint toward the potential of decreasing E.
coli viability in the mammary gland by targeting E. coli’s iron
acquisition mechanisms.
In conclusion, the inability of E. coli to produce Ent results
in a decreased bacterial fitness of E. coli in the murine
mastitic mammary gland by a reduced bacterial load and,
consequently, a diminished associated inflammatory response.
Our study therefore identifies Ent interference as a potential
target to decrease E. coli growth in the mastitic mammary gland,
although several in vitro follow-up experiments remain to fully
understand the complex interaction between involvement of iron
availability, immunity, and an E. coli infection. In addition, future
research in dairy cattle remains necessary to assess if interference
with bacterial Ent indeed has antimicrobial potential in the
bovine udder.
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